Filter by: Subject

Filter by: Subject

Results Per Page:

Globus pallidus internus (GPi) (1)
Glucocerebrosidase (GBA) (1)
Guillain-Barré syndrome (1)
Guillain–Barré syndrome (1)
Haematopoietic stem cell transplantation (HSCT) (1)
Head bobbing (1)
Hemichorea-Athetose (1)
Henk w. mauser grading (1)
Hepatic porphyrias (1)
Hiv infections (1)
HIV infections -- Complications -- South Africa (1)
HIV pandemic (1)
HIV-negative (1)
HIV-positive patients (1)
HIV-positive persons -- South Africa (1)
HIV-related neurology patients (1)
HTLV-associated myelopathy (HAM) (1)
Human T-cell lymphotropic virus (HTLV) (1)
Hypercoagulability (1)
Infection (1)
Inflammatory signalling (1)
Inhalant abuse (1)
Intellectual disability (1)
Intracranial subdural empyema (1)
Isolated generalised dystonia (IGD) (1)
John Cunningham (JC) virus (1)
John Cunningham virus (1)
Ketotische Hyperglykämie (1)
Kyphosis (1)
Leucoencephalopathy (1)
Light therapy (1)
Listeria meningitis (1)
LRRK2 gene (1)
Lsteriosis (1)
Lytic infection (1)
Medical treatment (1)
Meningitis south africa (1)
Metabolic syndrome (1)
Mitochondrial neurogastrointestinal encephalopathy (MNGIE) (1)
Mortality (1)
Muscle disease (1)
Myocardium -- Diseases (1)
Myoclonic seizures (1)
Nervous system -- Diseases -- Diagnosis -- South Africa (1)
Neuro-Behçet disease (NBD) (1)
Neurodegeneration (1)
Neurofibromatosis type 1 (1)
Neurological disorder (1)
Neurological manifestations of general diseases (1)
Neurological syndrome (1)
Neurology -- Research (1)
Neuromuscular disease (1)
Non-amyloid β-component (NAC) (1)
Nutraceuticals (1)
Obsessive-compulsive disorder (OCD) (1)
Oculopharyngeal muscular dystrophy (OPMD) (1)
Olfaction (1)
Olfactory bulb (1)
PABPN1 gene (1)
Parkinson's disease (1)
Parkinsonism (1)
Paroxysmal dyskinesia (1)
Paroxysmal nonkinesigenic dyskinesia (PNKD) (1)
Patient (1)
Patient mortality data (1)
Pedagogy (1)
Phakomatoses (1)
Phenotype (1)
Photobiomodulation (1)
Platelets (1)
Polyadenylate binding protein nuclear 1 (PABPN1) (1)
Porphyria (1)
Posterior reversible encephalopathy syndrome (PRES) (1)
PP2A Phosphatase Activator (PTPA) (1)
Pretoria, South Africa (1)
Prognostic indicators (1)
Progressive multifocal leucoencephalopathy (PML) (1)
Progressive multifocal leukoencephalopathy (PML) (1)
Protein phosphatase 2A complex (PP2A) (1)
Pseudo-tumors (1)